TERF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.528000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.104800E-01
Normal-vs-Stage2
4.551400E-01
Normal-vs-Stage3
1.069380E-01
Normal-vs-Stage4
9.488800E-01
Stage1-vs-Stage2
4.415800E-01
Stage1-vs-Stage3
3.123500E-02
Stage1-vs-Stage4
3.604200E-02
Stage2-vs-Stage3
4.322200E-02
Stage2-vs-Stage4
4.400100E-02
Stage3-vs-Stage4
1.801890E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.459400E-01
Normal-vs-AfricanAmerican
5.727600E-01
Normal-vs-Asian
3.647200E-01
Caucasian-vs-AfricanAmerican
1.502610E-01
Caucasian-vs-Asian
3.569800E-01
AfricanAmerican-vs-Asian
2.291500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.469200E-01
Normal-vs-Female
4.587600E-01
Male-vs-Female
8.267400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.542800E-01
Normal-vs-Age(41-60Yrs)
5.174800E-01
Normal-vs-Age(61-80Yrs)
7.137800E-02
Normal-vs-Age(81-100Yrs)
4.587200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.655400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.322000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.424200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.724200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.785200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.559000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.320100E-02
Normal-vs-Daily Drinker
6.138100E-02
Normal-vs-Weekly Drinker
1.222790E-01
Normal-vs-Occasional Drinker
2.405600E-01
Normal-vs-Social Drinker
5.105800E-01
Non Drinker-vs-Daily Drinker
7.860000E-01
Non Drinker-vs-Weekly Drinker
7.957000E-01
Non Drinker-vs-Occasional Drinker
1.878370E-01
Non Drinker-vs-Social Drinker
2.658000E-01
Daily Drinker-vs-Weekly Drinker
6.349800E-01
Daily Drinker-vs-Occasional Drinker
1.411990E-01
Daily Drinker-vs-Social Drinker
1.935370E-01
Weekly Drinker-vs-Occasional Drinker
3.708600E-01
Weekly Drinker-vs-Social Drinker
4.478200E-01
Occasional Drinker-vs-Social Drinker
8.552800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.226240E-01
Normal-vs-Grade 2
1.914150E-02
Normal-vs-Grade 3
4.439000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.313000E-01
Grade 1-vs-Grade 3
3.119200E-01
Grade 1-vs-Grade 4
1.226240E-01
Grade 2-vs-Grade 3
5.175800E-01
Grade 2-vs-Grade 4
1.914150E-02
Grade 3-vs-Grade 4
4.439000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.779800E-02
Normal-vs-NonDiabetic
4.324600E-01
Diabetic-vs-NonDiabetic
8.251000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.145800E-01
Normal-vs-NoPancreatitis
4.342400E-01
Pancreatitis-vs-NoPancreatitis
7.812000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.671400E-01
Normal-vs-N1
4.584800E-01
N0-vs-N1
9.013000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.205800E-01
Normal-vs-TP53-NonMutant
2.715200E-01
TP53-Mutant-vs-TP53-NonMutant
6.356400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
